Frailty care for older stomach cancer patients after surgery
Part of Cancer, Digestive system clinical trials.
This study tests a frailty assessment and intervention program for people aged 65+ with stage II or III stomach cancer who will have surgery and chemotherapy afterward. It aims to improve recovery and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years or older.
- You have been diagnosed with stage II or III stomach cancer.
- You are scheduled to have surgery to remove the cancer.
- You will start chemotherapy within 4–8 weeks after your surgery.
- You are able to communicate and cooperate with the study team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special geriatric (older-adult) care program for people over 65 with advanced stomach, bile duct, or pancreatic cancer who are receiving palliative chemotherapy. The goal is to see if extra support from a geriatric team can help improve quality of life and treatment outcomes.
This trial studies how “frailty” affects people with gastrointestinal (gut) cancer who are about to have major surgery, sometimes after chemotherapy or other treatment beforehand. It may help doctors better prepare and support patients through surgery.
This study looks at how frailty affects recovery and outcomes for patients aged 70 and older who are having planned surgery to remove colorectal cancer. The goal is to better understand frailty's impact so care can be improved.
This trial studies how older stomach cancer survivors' eating habits change after surgery and tests ways to help them eat healthier. It focuses on people who just had their stomach cancer removed.
This trial studies a “prehabilitation” program—exercise and coaching before surgery—to help frail older adults recover better after major digestive cancer surgery. It may help you strengthen your body and function before the operation, which can improve outcomes after surgery.
This study looks at how certain blood markers (albumin/creatine ratio, vitamin B12, and folate) relate to frailty in older adults having surgery for stomach or intestinal cancer. The goal is to understand if these markers can help predict which patients may be more frail.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.